Medicine and Dentistry
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
100%
Parkinson's Disease
52%
Relaxation
38%
Small Intestine
33%
Detrusor
33%
Muscle Contractility
33%
Bladder
33%
Colon
33%
Smooth Muscle
29%
Nitric Oxide
16%
Myenteric Plexus
14%
Vasoactive Intestinal Polypeptide
14%
Immunoreactivity
14%
Symptom
14%
Functional Gastrointestinal Disorder
13%
Carbachol
12%
Intestine Function
8%
Nitric Oxide Synthase Inhibitor
8%
5-HT Receptors
8%
Analysis
8%
N(g) Nitroarginine
6%
Therapeutic Procedure
6%
Adult
6%
Alpha Synuclein
6%
Intestine Innervation
6%
Epithelium
6%
Inflammation
6%
Muscle Contraction
6%
DOPA
6%
Noradrenalin
5%
Dopamine 1 Receptor Stimulating Agent
5%
Dopamine 2 Receptor Stimulating Agent
5%
3 (1 Adamantyl) 1 Aminomethyl 3,4 Dihydro 5,6 Dihydroxy 1h 2 Benzopyran
5%
Ropinirole
5%
Stimulation
5%
Neuroscience
Tetrahydropyridine
66%
Parkinson's Disease
52%
Dopaminergic
37%
Corticotropin-Releasing Hormone
33%
Basal Ganglia
33%
Central Nucleus of the Amygdala
33%
Female Rats
33%
MPTP
33%
Cholinergic
18%
Striatum
16%
Nitric Oxide
16%
Behavior (Neuroscience)
14%
Vasoactive Intestinal Peptide
14%
Carbachol
12%
Tyrosine Hydroxylase
8%
Substantia nigra
8%
Dopamine
8%
Vesicular Monoamine Transporter 2
8%
Neuroeffector Junction
8%
Non-Motor Symptoms
8%
Neurotransmitter
8%
L-DOPA
6%
Epithelium
6%
Nitroarginine
6%
Enteric Nervous System
6%
Choline Acetyltransferase
6%
Alpha-Synuclein
6%
Lipopolysaccharide
6%
Anxiety
6%
Neuron
6%
Ganglion
6%
D2-Receptor Agonists
5%
Ropinirole
5%
Norepinephrine
5%
D1-Receptor Agonists
5%
Atropine
5%
Dopamine Receptor D1
5%
Adenosine Triphosphate
5%
Histamine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Primate
77%
Callithrix jacchus
40%
Receptor Agonist
33%
Methcathinone
33%
Animal
16%
Callitrichinae
14%
Pharmacotherapy
9%
